Ryniant Raises $300K to Accelerate the Future of Molecular Innovation

Arizona’s startup ecosystem continues to produce founders tackling some of the world's most complex challenges.

This week, Phoenix-based startup Ryniant announced the successful close of a $300,000 pre-seed funding round led by Verdict Capital's Niko Bonatsos and Michael Fertik. The funding marks a major milestone for the company as it expands its AI-powered platform for pharmaceutical research organizations.

Founded by Arnav Simha, Naitik Mohanty, and Akarsh Jain, Ryniant is building an AI synthesis planning platform designed specifically for pharmaceutical contract research organizations (CROs). The platform dramatically reduces the time required to determine how a target molecule should be synthesized — a process that traditionally requires hours of work from experienced chemists.

Today, senior researchers often spend significant time evaluating reaction pathways, cross-referencing scientific databases, assessing feasibility, estimating costs, and preparing quotes for customers. Ryniant's platform streamlines this workflow, reducing a process that can take hours into one that can be completed in minutes.

But Ryniant's vision extends far beyond pharmaceutical research.

The company describes itself as a research-driven organization building AI-native platforms for molecular innovation across human health, advanced materials, and environmental resilience. Their mission is rooted in a bold belief: molecules are infrastructure. By transforming how molecules are discovered, engineered, and deployed, Ryniant believes it can help reshape industries ranging from medicine to manufacturing and sustainability.

That vision has already earned national recognition. Ryniant was recently selected for Launch Founders University Cohort 11, joining just 300 startups chosen from more than 3,000 applicants nationwide.

The company's approach reflects a growing trend within Arizona's innovation ecosystem: founders applying advanced artificial intelligence to highly technical industries where efficiency gains can create enormous economic and scientific value.

As Arizona continues to emerge as a leading hub for semiconductors, defense technology, biotechnology, and artificial intelligence, startups like Ryniant demonstrate the state's increasing ability to produce globally relevant innovation.

With fresh capital, active pilots, and early customers already using the platform, the team is positioned to accelerate product development and expand its impact across the molecular sciences.

For Arizona's startup community, Ryniant represents another example of ambitious founders building frontier technology from the desert.

And they're just getting started.